ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines (Q37056071)

18 August 2017

1 reference

title

ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines (English)

1 reference

attention deficit hyperactivity disorder

18 August 2017

0 references

0 references

author name string

Scott H Kollins

series ordinal

1

1 reference

18 August 2017

11 January 2008

1 reference

Journal of Attention Disorders

18 August 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 August 2017

12

1 reference

18 August 2017

115-125

1 reference

18 August 2017

2

1 reference

Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD

18 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Altered responsiveness to cocaine in rats exposed to methylphenidate during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Driving impairments in teens and adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Patterns of simultaneous polysubstance use in drug using university students

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

The protective effects of good parenting on adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: individuals with symptoms of attention-deficit/hyperactivity disorder and conduct disorder are uniquely at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Risk taking and novelty seeking in adolescence: introduction to part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Poison centers' experience with methylphenidate abuse in pre-teens and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

The neurobiology of drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Hyperactive boys almost grown up. V. Replication of psychiatric status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Medical use, illicit use, and diversion of abusable prescription drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Medical use, illicit use and diversion of prescription stimulant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Factors that predict individual vulnerability to amphetamine self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Sensitization and tolerance in psychostimulant self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Adolescent brain development and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Stimulant medications: how to minimize their reinforcing effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Attention Deficit Hyperactivity Disorder (ADHD) is Associated with Early Onset Substance Use Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Relationship of child psychopathology to parental alcoholism and antisocial personality disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

Psychostimulant Treatment and Risk for Substance Abuse Among Young Adults with a History of Attention-Deficit/Hyperactivity Disorder: APopulation-Based, Birth Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707311654

21 January 2018

Identifiers

DOI

10.1177/1087054707311654

1 reference

18 August 2017

1 reference

PubMed ID

18192623